BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 15456408)

  • 1. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
    Muñoz-Gámez JA; Martín-Oliva D; Aguilar-Quesada R; Cañuelo A; Nuñez MI; Valenzuela MT; Ruiz de Almodóvar JM; De Murcia G; Oliver FJ
    Biochem J; 2005 Feb; 386(Pt 1):119-25. PubMed ID: 15456408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells.
    Muñoz-Gámez JA; Quiles-Pérez R; Ruiz-Extremera A; Martín-Álvarez AB; Sanjuan-Nuñez L; Carazo A; León J; Oliver FJ; Salmerón J
    Cancer Lett; 2011 Feb; 301(1):47-56. PubMed ID: 21093979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer.
    Schlicker A; Peschke P; Bürkle A; Hahn EW; Kim JH
    Int J Radiat Biol; 1999 Jan; 75(1):91-100. PubMed ID: 9972795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis.
    Noël G; Godon C; Fernet M; Giocanti N; Mégnin-Chanet F; Favaudon V
    Mol Cancer Ther; 2006 Mar; 5(3):564-74. PubMed ID: 16546970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.
    Wu GS; Ding Z
    Oncogene; 2002 Jan; 21(1):1-8. PubMed ID: 11791171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of PARP-1 inhibitor 4-amino-1 ,8-naphthalimide on the on the sensitivity of adriamycin].
    Jiang X; Liu S; Deng W; Zhao W; Wu M; Zhang Z
    Wei Sheng Yan Jiu; 2012 Mar; 41(2):173-9. PubMed ID: 22611920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP-1 is involved in autophagy induced by DNA damage.
    Muñoz-Gámez JA; Rodríguez-Vargas JM; Quiles-Pérez R; Aguilar-Quesada R; Martín-Oliva D; de Murcia G; Menissier de Murcia J; Almendros A; Ruiz de Almodóvar M; Oliver FJ
    Autophagy; 2009 Jan; 5(1):61-74. PubMed ID: 19001878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
    Luo Q; Li Y; Lai Y; Zhang Z
    J Toxicol Sci; 2015 Jun; 40(3):349-63. PubMed ID: 25972196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation.
    Boehrer S; Chow KU; Beske F; Kukoc-Zivojnov N; Puccetti E; Ruthardt M; Baum C; Rangnekar VM; Hoelzer D; Mitrou PS; Weidmann E
    Cancer Res; 2002 Mar; 62(6):1768-75. PubMed ID: 11912153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.
    Nabha SM; Mohammad RM; Dandashi MH; Coupaye-Gerard B; Aboukameel A; Pettit GR; Al-Katib AM
    Clin Cancer Res; 2002 Aug; 8(8):2735-41. PubMed ID: 12171907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria.
    Yu W; Sanders BG; Kline K
    Cancer Res; 2003 May; 63(10):2483-91. PubMed ID: 12750270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis by the inhibitors of poly(ADP-ribose)polymerase in HeLa cells.
    Ghosh U; Bhattacharyya NP
    Mol Cell Biochem; 2009 Jan; 320(1-2):15-23. PubMed ID: 18695944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
    Bryant HE; Helleday T
    Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expression.
    Mariano G; Ricciardi MR; Trisciuoglio D; Zampieri M; Ciccarone F; Guastafierro T; Calabrese R; Valentini E; Tafuri A; Del Bufalo D; Caiafa P; Reale A
    Oncotarget; 2015 Jun; 6(17):15008-21. PubMed ID: 25938539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts.
    García S; Bodaño A; Pablos JL; Gómez-Reino JJ; Conde C
    Ann Rheum Dis; 2008 May; 67(5):631-7. PubMed ID: 17890271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria-mediated apoptosis operating irrespective of multidrug resistance in breast cancer cells by the anticancer agent prodigiosin.
    Soto-Cerrato V; Llagostera E; Montaner B; Scheffer GL; Perez-Tomas R
    Biochem Pharmacol; 2004 Oct; 68(7):1345-52. PubMed ID: 15345324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
    Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M
    Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells.
    Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Smulson ME
    Cancer Res; 1999 May; 59(9):2190-4. PubMed ID: 10232607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release.
    Hermisson M; Wagenknecht B; Wolburg H; Glaser T; Dichgans J; Weller M
    Oncogene; 2000 May; 19(19):2338-45. PubMed ID: 10822385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells.
    Mooney LM; Al-Sakkaf KA; Brown BL; Dobson PR
    Br J Cancer; 2002 Oct; 87(8):909-17. PubMed ID: 12373608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.